A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
一项针对转移性去势抵抗性前列腺癌的抗体药物偶联物ASG-5ME(一种靶向SLC44A4并携带奥瑞他汀E的抗体)的I期研究
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-019-00731-5
McHugh, Deaglan; Eisenberger, Mario; Heath, Elisabeth I; Bruce, Justine; Danila, Daniel C; Rathkopf, Dana E; Feldman, Jarett; Slovin, Susan F; Anand, Banmeet; Chu, Rong; Lackey, Jacqueline; Reyno, Leonard; Antonarakis, Emmanuel S; Morris, Michael J